nach oben

Erschienen in:

03.06.2022 | Original Article

Retrospective analysis: 5509 cases of “totally implantable venous access port systems implantation (TIVAPS) depth” assisted by digital radiography

verfasst von: Kuo Chen, Jin Zhang, Narasimha M. Beeraka, Yuanting Gu, Jingruo Li, Na Han, Mikhail Y. Sinelnikov, Pengwei Lu

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 7/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Modern oncological treatment in breast cancer patients requires the precise delivery of chemotherapy infusion into the central venous systems without toxicity. TIVAPS is the significant method of chemotherapy delivery although certain internal or external complications associated with their placement. However, the long-term use of TIVAPS is still a concern to minimize the complications such as venous thrombosis syndrome (VTS) and cardiac defects. The aim of this study is to investigate the potential disadvantages that may be avoided by digital radiography (DR)-assisted measurement of catheter depth pertinent to TIVAPS implanted system.

Methods

Retrospective analysis related to 5509 TIVAPS recipients of 99% female breast cancer patients and 1% male blood disorder patients registered from April 2013 to November 2017 were included in the study. Patients with TIVAPS catheter tip depth into superior vena cava into upper (group A), middle (group B), and lower (group C) parts were stratified for evaluation during implantation; DR-assisted measurement of TIVAPS was performed to decipher “tip depth of catheter” and determined the relevance of tip depth to complications such as VTS and cardiac defects.

Results

Incidence of VTS complications were significantly higher in TIVAPS recipients of group A (82.7%) than group B (16%) and group C (0.12%) in which the “tip depth of TIVAPS was deeper” (P < 0.01). Defects in heart function are higher in group C (59.6%) than group A (15.8%) and group B (24.6%) in which the “tip depth of TIVAPS was deeper” (P < 0.01).

Conclusion

DR-assisted measurement can more accurately determine the depth of TIVAPS catheter implantation, and avoid the incidence of related complications, and provide a better method for surgeons.

Narducci F, Jean-Laurent M, Boulanger L, El Bédoui S, Mallet Y, Houpeau J, Hamdani A, Penel N, Fournier C (2011) Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre. Eur J Surg Oncol (EJSO) 37:913–918CrossRefPubMed

Beckers M, Ruven H, Seldenrijk C, Prins M, Biesma DH (2010) Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer. Thromb Res 125:318–321CrossRefPubMed

Pinelli F, Cecero E, DeglInnocenti D, Selmi V, Giua R, Villa G, Chelazzi C, Romagnoli S, Pittiruti M (2018) Infection of totally implantable venous access devices: a review of the literature. J Vasc Access 19:230–242CrossRefPubMed

Dallavalasa S, Beeraka NM, Basavaraju CG, Tulimilli SV, Sadhu SP. Rajesh K, Aliev G, Madhunapantula SV (2021) The role of tumor associated macrophages (TAMs) in cancer progression, chemoresistance, angiogenesis and metastasis-current status. Current Medicinal Chemistry.

Chen K, M Beeraka N, Zhang J, Reshetov IV, Nikolenko VN, Sinelnikov MY, Mikhaleva LM. (2021) Efficacy of da Vinci robot‐assisted lymph node surgery than conventional axillary lymph node dissection in breast cancer–a comparative study. The International Journal of Medical Robotics and Computer Assisted Surgery e2307.

Chen K, Beeraka NM, Li J, Lu, P. (2021) Anterior abdominal wall defect closed by the anterior sheath of the upper rectus abdominis muscle in a patient with prior “TRAM flap breast reconstruction”. Indian Journal of Surgery 1–3.

Beeraka NM, Bovilla VR, Doreswamy SH, Puttalingaiah S, Srinivasan A, Madhunapantula SV (2021) The taming of nuclear factor erythroid-2-related factor-2 (Nrf2) deglycation by fructosamine-3-kinase (FN3K)-inhibitors-a novel strategy to combat cancers. Cancers 13:281CrossRefPubMedPubMedCentral

Yildizeli B, Lacin T, Batirel H, Yüksel M (2004) Complications and management of long-term central venous access catheters and ports. J Vasc Access 5:174–178CrossRefPubMed

Biffi R, Orsi F, Pozzi S, Pace U, Bonomo G, Monfardini L, Della Vigna P, Rotmensz N, Radice D, Zampino M (2009) Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial. Ann Oncol 20:935–940CrossRefPubMed

10.

Hartkamp A, Van Boxtel A, Zonnenberg B, Witteveen P (2000) Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems. Neth J Med 57:215–223CrossRefPubMed

11.

Ma L, Liu Y, Wang J, Chang Y, Yu L, Geng C (2016) Totally implantable venous access port systems and associated complications: a single-institution retrospective analysis of 2,996 breast cancer patients. Mol Clin Oncol 4:456–460CrossRefPubMedPubMedCentral

12.

Chopra V, Flanders SA, Saint S, Woller SC, O’Grady NP, Safdar N, Trerotola SO, Saran R, Moureau N, Wiseman S (2015) The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): results from a multispecialty panel using the RAND/UCLA appropriateness method. Ann Intern Med 163:S1–S40CrossRefPubMed

13.

Niederhuber J, Ensminger W, Gyves J, Liepman M, Doan K, Cozzi E (1982) Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 92:706–712PubMed

14.

Di Carlo I, Cordio S, La Greca G, Privitera G, Russello D, Puleo S, Latteri F (2001) Totally implantable venous access devices implanted surgically: a retrospective study on early and late complications. Arch Surg 136:1050–1053CrossRefPubMed

15.

Gallichio MH, Kahn D, Lempert N, Conti DJ (1994) Placement of a double lumen silastic catheter for hemodialysis access through the cephalic vein. J Am Coll Surg 178:171–172PubMed

16.

Knebel P, Fischer L, Huesing J, Hennes R, Büchler M, Seiler C (2009) Randomized clinical trial of a modified Seldinger technique for open central venous cannulation for implantable access devices. J British Surg 96:159–165CrossRef

17.

Lorch H, Zwaan M, Kagel C, Weiss H-D (2001) Central venous access ports placed by interventional radiologists: experience with 125 consecutive patients. Cardiovasc Intervent Radiol 24:180–184CrossRefPubMed

18.

Lyon RD, Griggs KA, Johnson AM, Olsen JR (1999) Long-term follow-up of upper extremity implanted venous access devices in oncology patients. J Vasc Interv Radiol 10:463–471CrossRefPubMed

19.

Nocito A, Wildi S, Rufibach K, Clavien P, Weber M (2009) Randomized clinical trial comparing venous cutdown with the Seldinger technique for placement of implantable venous access ports. J British Surg 96:1129–1134CrossRef

20.

Povoski SP (2000) A prospective analysis of the cephalic vein cutdown approach for chronic indwelling central venous access in 100 consecutive cancer patients. Ann Surg Oncol 7:496–502CrossRefPubMed

21.

Seiler CM, Frohlich BE, Dorsam UJ, Kienle P, Buchler MW, Knaebel HP (2006) Surgical technique for totally implantable access ports (TIAP) needs improvement: a multivariate analysis of 400 patients. J Surg Oncol 93:24–29CrossRefPubMed

22.

Shetty P, Mody MK, Kastan DJ, Sharma RP, Burke MW, Venugopal C, Burke TH (1997) Outcome of 350 implanted chest ports placed by interventional radiologists. J Vasc Interv Radiol 8:991–995CrossRefPubMed

23.

Simpson KR, Hovsepian DM, Picus D (1997) Interventional radiologic placement of chest wall ports: results and complications in 161 consecutive placements. J Vasc Interv Radiol 8:189–195CrossRefPubMed

24.

Lebeaux D, Fernández-Hidalgo N, Chauhan A, Lee S, Ghigo J-M, Almirante B, Beloin C (2014) Management of infections related to totally implantable venous-access ports: challenges and perspectives. Lancet Infect Dis 14:146–159CrossRefPubMed

25.

Becker F, Wurche LA, Darscht M, Pascher A, Struecker B (2021) Totally implantable venous access port insertion via open Seldinger approach of the internal jugular vein—a retrospective risk stratification of 500 consecutive patients. Langenbecks Arch Surg 406:903–910CrossRefPubMedPubMedCentral

26.

Hsu CCT, Kwan GN, Evans‐Barns H, Rophael JA, van Driel ML. (2016) Venous cutdown versus the Seldinger technique for placement of totally implantable venous access ports. Cochrane Database of Systematic Reviews.

27.

Di Carlo I, Barbagallo F, Toro A, Sofia M, Lombardo R, Cordio S (2005) External jugular vein cutdown approach, as a useful alternative, supports the choice of the cephalic vein for totally implantable access device placement. Ann Surg Oncol 12:570–573CrossRefPubMed

28.

Di Carlo I, Pulvirenti E, Mannino M, Toro A (2010) Increased use of percutaneous technique for totally implantable venous access devices. Is it real progress? A 27-year comprehensive review on early complications. Ann Surg Oncol 17:1649–1656CrossRefPubMed

29.

Reddy BD, Beeraka NM, Chitturi C, Madhunapantula SV. (2021) An overview of targeting legumain for inhibiting cancers. Current Pharmaceutical Design

30.

Gilyazova IR, Beeraka NM, Klimentova EA, Bulygin KV, Nikolenko VN, Izmailov AA, Gilyazova GR, Pavlov VN, Khusnutdinova EK, Somasundaram SG (2021) Novel microRNA binding site SNPs and the risk of clear cell renal cell carcinoma (ccRCC): a case-control study. Curr Cancer Drug Targets 21:203–212CrossRef

31.

Chen K, Lu P, Beeraka NM, Sukocheva OA, Madhunapantula SV, Liu J, Sinelnikov MY, Nikolenko VN, Bulygin KV, Mikhaleva LM. (2020) Mitochondrial mutations and mitoepigenetics: focus on regulation of oxidative stress-induced responses in breast cancers. In Proceedings of the Seminars in Cancer Biology.

32.

Beeraka NM, Doreswamy SH, Sadhu SP, Srinivasan A, Pragada RR, Madhunapantula SV, Aliev G (2020) The role of exosomes in stemness and neurodegenerative diseases—chemoresistant-cancer therapeutics and phytochemicals. Int J Mol Sci 21:6818CrossRefPubMedPubMedCentral

33.

Manogaran P, Beeraka NM, Padma VV (2019) The cytoprotective and anti-cancer potential of bisbenzylisoquinoline alkaloids from Nelumbo nucifera. Curr Top Med Chem 19:2940–2957CrossRefPubMed

34.

Manogaran P, Beeraka NM, Huang C-Y, Padma VV (2019) Neferine and isoliensinine from Nelumbo nucifera induced reactive oxygen species (ROS)-mediated apoptosis in colorectal cancer HCT-15 cells. Afr J Pharm Pharmacol 13:90–99CrossRef

35.

Manogaran P, Beeraka NM, Huang C-Y, Padma VV (2019) Neferine and isoliensinine enhance ‘intracellular uptake of cisplatin’and induce ‘ROS-mediated apoptosis’ in colorectal cancer cells–a comparative study. Food Chem Toxicol 132:110652CrossRefPubMed

36.

Yang S-S, Ahn MS (2018) A comparison between upper arm and chest for optimal site of totally implanted venous access ports in patients with female breast cancer. Ann Vasc Surg 50:128–134CrossRefPubMed

37.

Biacchi D, Sammartino P, Sibio S, Accarpio F, Cardi M, Sapienza P, De Cesare A, Atta JMF, Impagnatiello A, Di Giorgio A (2016) Does the implantation technique for totally implantable venous access ports (TIVAPs) influence long-term outcome? World J Surg 40:284–290CrossRefPubMed

38.

Qi F, Cheng H, Yuan X, Zhang L (2020) Comparison of PICC and TIVAP in chemotherapy for patients with thyroid cancer. Oncol Lett 20:1657–1662CrossRefPubMedPubMedCentral

39.

Debourdeau P, Espié M, Chevret S, Gligorov J, Elias A, Dupré PF, Desseaux K, Kalidi I, Villiers S, Giachetti S (2017) Incidence, risk factors, and outcomes of central venous catheter-related thromboembolism in breast cancer patients: the CAVECCAS study. Cancer Med 6:2732–2744CrossRefPubMedPubMedCentral

40.

Goltz JP, Schmid JS, Ritter CO, Knödler P, Petritsch B, Kirchner J, Hahn D, Kickuth R (2012) Identification of risk factors for catheter-related thrombosis in patients with totally implantable venous access ports in the forearm. J Vasc Access 13:79–85CrossRefPubMed

41.

Kuo Chen NMB, Yuanting Gu, Jingruo Li, Mikhail Sinelnikov, Nan H, Pengwei L. (2021) Totally implantable venous access port systems: implant depth-based complications in breast cancer therapy - a comparative study. Current Pharmaceutical Design, Bentham Science. https://doi.org/10.2174/1381612827666210901170522.

42.

Caers J, Fontaine C, Vinh-Hung V, De Mey J, Ponnet G, Oost C, Lamote J, De Greve J, Van Camp B, Lacor P (2005) Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports. Support Care Cancer 13:325–331CrossRefPubMed

43.

Puel V, Caudry M, Le Métayer P, Baste JC, Midy D, Marsault C, Demeaux H, Maire JP (1993) Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports. Cancer 72:2248–2252CrossRefPubMed

44.

Zhang Y, Shi J, Li J-j, Zhang L, Li Y. (2021) Systemic thrombolysis and anticoagulation therapy for catheter-related right atrial thrombosis caused by TIVAP: a case report and review of the literature. The Journal of Vascular Access 1129729821989159.

45.

Lee A, Levine MN, Butler G, Webb C, Costantini L, Gu C, Julian JA (2006) Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol 24:1404–1408CrossRefPubMed

46.

Goltz JP, Machann W, Noack C, Hahn D, Kickuth R (2011) Feasibility of power contrast injections and bolus triggering during CT scans in oncologic patients with totally implantable venous access ports of the forearm. Acta Radiol 52:41–47CrossRefPubMed

47.

Voog E, Campion L, Du Rusquec P, Bourgeois H, Domont J, Denis F, Emmanuel E, Dupuis O, Ganem G, Lafont C (2018) Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer. Support Care Cancer 26:81–89CrossRefPubMed

48.

Surov A, Rusner C, Weigand K, John E, Spielmann RP, Behrmann C (2012) Radio-opacity and incidental identified mechanical complications of totally implantable venous access devices placed in the chest. Acta Radiol 53:1035–1039CrossRefPubMed

Titel: Retrospective analysis: 5509 cases of “totally implantable venous access port systems implantation (TIVAPS) depth” assisted by digital radiography
verfasst von: Kuo Chen
Jin Zhang
Narasimha M. Beeraka
Yuanting Gu
Jingruo Li
Na Han
Mikhail Y. Sinelnikov
Pengwei Lu
Publikationsdatum: 03.06.2022
Verlag: Springer Berlin Heidelberg
Erschienen in: Langenbeck's Archives of Surgery / Ausgabe 7/2022
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI: https://doi.org/10.1007/s00423-022-02573-x

Neu im Fachgebiet Chirurgie

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Retrospective analysis: 5509 cases of “totally implantable venous access port systems implantation (TIVAPS) depth” assisted by digital radiography